Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

ClinicalTrials.gov ID: NCT00260078

Public ClinicalTrials.gov record NCT00260078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Intensive Pharmacokinetic Studies of Antiretroviral Drug Combinations in Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Limited data exist about combination anti-HIV treatment regimens in children, including how those drugs are cleared by the body in children. The purpose of this study is to measure the blood levels of the following combinations of anti-HIV drugs in HIV infected chilren: tenofovir disoproxil fumurate (TDF) and efavirenz (EFV) or nevirapine (NVP); TDF and darunavir (DRV) with or without EFV; and TDF and ritonavir (RTV) with or without EFV.

Study identification

NCT ID
NCT00260078
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
75 participants

Conditions and interventions

Eligibility (public fields only)

Age range
8 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Apr 2009 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Nov 9, 2021

2006 – 2009

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Usc La Nichd Crs Alhambra California 91803 —
University of California, UC San Diego CRS La Jolla California 92093-0672 —
Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach California 90806 —
Harbor UCLA Medical Ctr. NICHD CRS Torrance California 90502 —
Connecticut Children's Med. Ctr. Hartford Connecticut 06106 —
Pediatric Perinatal HIV Clinical Trials Unit CRS Miami Florida 33136 —
Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago Illinois 60612 —
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS Chicago Illinois 60614-3393 —
Univ. of Maryland Baltimore NICHD CRS Baltimore Maryland 21201 —
Johns Hopkins Univ. Baltimore NICHD CRS Baltimore Maryland 21287 —
Children's Hosp. of Boston NICHD CRS Boston Massachusetts 02115 —
Baystate Health, Baystate Med. Ctr. Springfield Massachusetts 01199 —
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01605 —
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201 —
Rutgers - New Jersey Medical School CRS Newark New Jersey 07103 —
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS Brooklyn New York 11203 —
Nyu Ny Nichd Crs New York New York 10016 —
Jacobi Med. Ctr. Bronx NICHD CRS The Bronx New York 10461 —
DUMC Ped. CRS Durham North Carolina 27710 —
St. Jude Children's Research Hospital CRS Memphis Tennessee 38105-3678 —
Seattle Children's Hospital CRS Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00260078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00260078 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →